{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:30:29Z","timestamp":1794004229619,"version":"4.8.0"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Neurological disorders are composed of several diseases that affect the central and peripheral nervous system; among these are neurodegenerative diseases, which lead to neuronal death. Many of these diseases have treatment for the disease and symptoms, leading pa-tients to use several drugs that cause side effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>The search for new treatments has led to the investigation of multi-target drugs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>This review aimed to investigate in the literature the multi-target effect in neurological disorders through an in silico approach. Studies were reviewed on the diseases such as epilepsy, Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, cerebral ischemia, and Parkinson's disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>As a result, the study emphasize the relevance of research by computational techniques such as quantitative structure-activity relationship (QSAR) prediction models, pharmacokinetic pre-diction models, molecular docking, and molecular dynamics, besides presenting possible drug can-didates with multi-target activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>It was possible to identify several targets with pharmacological activities. Some of these targets had diseases in common such as carbonic anhydrase, acetylcholinesterase, NMDA, and MAO being relevant for possible multi-target approaches.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026623666230126112628","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T06:52:58Z","timestamp":1674802378000},"page":"349-370","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Challenges and Discoveries in Polypharmacology of Neurodegenerative\nDiseases"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-4107","authenticated-orcid":true,"given":"Luciana","family":"Scotti","sequence":"first","affiliation":[{"name":"Health Science Center, Federal University of Para\u00edba, 50670-910, Jo\u00e3o Pessoa, PB, Brazil"},{"name":"Teaching and Research Management-University Hospital, Federal University of Para\u00edba, Jo\u00e3o Pessoa, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Carolliny Moreira","family":"Lustoza Rodrigues","sequence":"additional","affiliation":[{"name":"Health Science Center, Federal University of Para\u00edba, 50670-910, Jo\u00e3o Pessoa, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Ferreira","family":"de Sousa","sequence":"additional","affiliation":[{"name":"Health Science Center, Federal University of Para\u00edba, 50670-910, Jo\u00e3o Pessoa, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Matilde Ferreira","family":"dos Santos","sequence":"additional","affiliation":[{"name":"Health Science Center, Federal University of Para\u00edba, 50670-910, Jo\u00e3o Pessoa, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan Dantas","family":"Aires Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Health Science Center, Federal University of Para\u00edba, 50670-910, Jo\u00e3o Pessoa, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Tullius","family":"Scotti","sequence":"additional","affiliation":[{"name":"Health Science Center, Federal University of Para\u00edba, 50670-910, Jo\u00e3o Pessoa, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"The burden of Neurological conditions in the Region of the Americas, 2000-2019\/ Pan American Health OrganizationAvailable from:"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/cells11050796","volume":"11","author":"Shou J.W.","year":"2022","unstructured":"Shou J.W.; Shaw P.C.; Therapeutic efficacies of berberine against neurological disorders: an update of pharmacological effects and mechanisms. Cells 2022,11(5),796","journal-title":"Cells"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000495197","volume":"52","author":"Feigin V.L.","year":"2019","unstructured":"Feigin V.L.; Vos T.; Global Burden of Neurological Disorders: From global burden of disease estimates to actions. Neuroepidemiology 2019,52(1-2),1-2","journal-title":"Neuroepidemiology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/cells11030463","volume":"11","author":"Storey C.L.","year":"2022","unstructured":"Storey C.L.; Williams R.S.B.; Fisher P.R.; Annesley S.J.; Dictyostelium discoideum: A model system for neurological disorders. Cells 2022,11,463","journal-title":"Cells"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/jdn.10101","volume":"81","author":"Ahani-Nahayati M.","year":"2021","unstructured":"Ahani-Nahayati M.; Shariati A.; Mahmoodi M.; Olegovna Zekiy A.; Javidi K.; Shamlou S.; Mousakhani A.; Zamani M.; Hassanzadeh A.; Stem cell in neurodegenerative disorders; an emerging strategy. Int J Dev Neurosci 2021,81(4),291-311","journal-title":"Int J Dev Neurosci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1002\/alz.12580","volume":"18","author":"Astillero-Lopez V.","year":"2022","unstructured":"Astillero-Lopez V.; Gonzalez-Rodriguez M.; Villar-Conde S.; Flores-Cuadrado A.; Martinez-Marcos A.; Ubeda-Banon I.; Saiz-Sanchez D.; Neurodegeneration and astrogliosis in the entorhinal cortex in Alzheimer\u2019s disease: Stereological layer\u2010specific assessment and proteomic analysis. Alzheimers Dement 2022,18(12),2468-2480","journal-title":"Alzheimers Dement"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1523\/JNEUROSCI.0782-21.2022","volume":"42","author":"Callahan J.W.","year":"2022","unstructured":"Callahan J.W.; Wokosin D.L.; Bevan M.D.; Dysregulation of the basal ganglia indirect pathway in early symptomatic Q175 huntington\u2019s disease mice. J Neurosci 2022,42(10),2080-2102","journal-title":"J Neurosci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"ncn3.12596","DOI":"10.1111\/ncn3.12596","author":"Adachi T.","year":"2022","unstructured":"Adachi T.; Hanajima R.; Neuropathological changes in advanced Parkinson\u2019s disease. Neurol Clin Neurosci 2022,ncn3.12596","journal-title":"Neurol Clin Neurosci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11356-022-19251-6\/FIGURES\/9","author":"Essawy A.E.","year":"2022","unstructured":"Essawy A.E.; El-Sayed S.A.; Tousson E.; Abd El-gawad, H.S.; Alhasani, R.H.; Abd Elkader, H.T.A.E. Anti-kindling effect of ginkgo biloba leaf extract and L-Carnitine in the pentylenetetrazol model of epilepsy. Environ Sci Pollut Res Int 2022,1-15","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4103\/1673-5374.322466","volume":"17","author":"Li T.H.","year":"2022","unstructured":"Li T.H.; Sun H.W.; Song L.J.; Yang B.; Zhang P.; Yan D.M.; Liu X.Z.; Luo Y.R.; Long non-coding RNA MEG3 regulates autophagy after cerebral ischemia\/reperfusion injury. Neural Regen Res 2022,17(4),824-831","journal-title":"Neural Regen Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/biology11020298","volume":"11","author":"You J.","year":"2022","unstructured":"You J.; Maksimovic K.; Lee J.; Khan M.; Masuda R.; Park J.; Selective Loss of MATR3 in spinal interneurons, upper motor neurons and Hippocampal CA1 neurons in a MATR3 S85C knock-in mouse model of amyotrophic lateral sclerosis. Biology 2022,11(2),298","journal-title":"Biology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"984338","DOI":"10.3389\/fgene.2022.984338","volume":"13","author":"Zhao N.","year":"2022","unstructured":"Zhao N.; Quicksall Z.; Asmann Y.W.; Ren Y.; Network approaches for omics studies of neurodegenerative diseases. Front Genet 2022,13,984338","journal-title":"Front Genet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-3-030-55035-6_15","volume":"1286","author":"Cagin U.","year":"2021","unstructured":"Cagin U.; Targeting age-related neurodegenerative diseases by AAV-Mediated gene therapy. Adv Exp Med Biol 2021,1286,213-223","journal-title":"Adv Exp Med Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","volume":"24","author":"Sun J.","year":"2021","unstructured":"Sun J.; Roy S.; Gene-based therapies for neurodegenerative diseases. Nat Neurosci 2021,24(3),297-311","journal-title":"Nat Neurosci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3390\/ijms22137213","volume":"22","year":"2021","unstructured":"Vuleti\u0107 V.; Ra&#x10D;ki, V.; Papi\u0107 E.; Peterlin, B. A systematic review of parkinson\u2019s disease pharmacogenomics: Is there time for translation into the clinics? Int J Mol Sci 2021,22(13),7213","journal-title":"Int J Mol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"654739","DOI":"10.3389\/fneur.2021.654739","volume":"12","author":"Mortada I.","year":"2021","unstructured":"Mortada I.; Farah R.; Nabha S.; Ojcius D.M.; Fares Y.; Almawi W.Y.; Sadier N.S.; Immunotherapies for neurodegenerative diseases. Front Neurol 2021,12,654739","journal-title":"Front Neurol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1566523220999200917114101","volume":"21","author":"Puranik N.","year":"2021","unstructured":"Puranik N.; Yadav D.; Chauhan P.S.; Kwak M.; Jin J.O.; Exploring the role of gene therapy for neurological disorders. Curr Gene Ther 2021,21(1),11-22","journal-title":"Curr Gene Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/med.21600","volume":"40","author":"Tomaselli D.","year":"2020","unstructured":"Tomaselli D.; Lucidi A.; Rotili D.; Mai A.; Epigenetic polypharmacology: A new frontier for epi\u2010drug discovery. Med Res Rev 2020,40(1),190-244","journal-title":"Med Res Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/bioinformatics\/btab566","volume":"38","author":"Nam S.","year":"2022","unstructured":"Nam S.; Lee S.; Park S.; Lee J.; Park A.; Kim Y.H.; Park T.; PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method. Bioinformatics 2022,38(2),444-452","journal-title":"Bioinformatics"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"636989","DOI":"10.3389\/fphar.2021.636989","volume":"12","author":"Pinzi L.","year":"2021","unstructured":"Pinzi L.; Tinivella A.; Caporuscio F.; Rastelli G.; Drug repurposing and polypharmacology to fight SARS-CoV-2 through inhibition of the main protease. Front Pharmacol 2021,12,636989","journal-title":"Front Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/17460441.2020.1767063","volume":"15","author":"Chaudhari R.","year":"2020","unstructured":"Chaudhari R.; Fong L.W.; Tan Z.; Huang B.; Zhang S.; An up-to-date overview of computational polypharmacology in modern drug discovery. Expert Opin Drug Discov 2020,15(9),1025-1044","journal-title":"Expert Opin Drug Discov"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13326-021-00258-w","volume":"13","author":"M&#xFC;ller B.","year":"2022","unstructured":"M&#xFC;ller B.; Castro L.J.; Rebholz-Schuhmann D.; Ontology-based identification and prioritization of candidate drugs for epilepsy from literature. J Biomed Semantics 2022,13(1),3","journal-title":"J Biomed Semantics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"104841","DOI":"10.1016\/j.neuint.2020.104841","volume":"140","author":"Advani D.","year":"2020","unstructured":"Advani D.; Gupta R.; Tripathi R.; Sharma S.; Ambasta R.K.; Kumar P.; Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach. Neurochem Int 2020,140,104841","journal-title":"Neurochem Int"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"768023","DOI":"10.3389\/fphar.2021.768023","volume":"12","author":"Shah S.","year":"2021","unstructured":"Shah S.; Dooms M.M.; Amaral-Garcia S.; Igoillo-Esteve M.; Current drug repurposing strategies for rare neurodegenerative disorders. Front Pharmacol 2021,12,768023","journal-title":"Front Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"119343","DOI":"10.1016\/j.lfs.2021.119343","volume":"274","author":"Sharma S.","year":"2021","unstructured":"Sharma S.; Nozohouri S.; Vaidya B.; Abbruscato T.; Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke. Life Sci 2021,274,119343","journal-title":"Life Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.9734\/jpri\/2021\/v33i31B31704","author":"Bhagat R.T.","year":"2021","unstructured":"Bhagat R.T.; Butle S.R.; Drug repurposing: A review. J Pharm Res Int 2021,161-169","journal-title":"J Pharm Res Int"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbpa.2021.06.001","volume":"65","author":"Urbina F.","year":"2021","unstructured":"Urbina F.; Puhl A.C.; Ekins S.; Recent advances in drug repurposing using machine learning. Curr Opin Chem Biol 2021,65,74-84","journal-title":"Curr Opin Chem Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21330-0","volume":"12","author":"Rodriguez S.","year":"2021","unstructured":"Rodriguez S.; Hug C.; Todorov P.; Moret N.; Boswell S.A.; Evans K.; Zhou G.; Johnson N.T.; Hyman B.T.; Sorger P.K.; Albers M.W.; Sokolov A.; Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s Disease. Nat Commun 2021,12(1),1-13","journal-title":"Nat Commun"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.genhosppsych.2021.12.002","volume":"74","author":"Hadlandsmyth K.","year":"2022","unstructured":"Hadlandsmyth K.; Bernardy N.C.; Lund B.C.; Central nervous system polytherapy among veterans with posttraumatic stress disorder: Changes across a decade. Gen Hosp Psychiatry 2022,74,46-50","journal-title":"Gen Hosp Psychiatry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12291-020-00946-x","volume":"37","author":"Dabla P.K.","year":"2022","unstructured":"Dabla P.K.; Sharma S.; Mir R.; Puri V.; Significant association of antiepileptic drug polytherapy with decreased FT4 levels in epileptic patients. Indian J Clin Biochem 2022,37(1),107-112","journal-title":"Indian J Clin Biochem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1080\/15287394.2021.1956661","volume":"84","author":"Kang Y.","year":"2021","unstructured":"Kang Y.; Jeong B.; Lim D.H.; Lee D.; Lim K.M.; In silico prediction of the full united nations globally harmonized system eye irritation categories of liquid chemicals by iata-like bottom-up approach of random forest method. J Toxicol Environ Health A 2021,84(23),960-972","journal-title":"J Toxicol Environ Health A"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/md20010053","volume":"20","author":"Llorach-Pares L.","year":"2022","unstructured":"Llorach-Pares L.; Nonell-Canals A.; Avila C.; Sanchez-Martinez M.; Computer-Aided Drug Design (CADD) to De-Orphanize marine molecules: Finding potential therapeutic agents for neurodegenerative and cardiovascular diseases. Mar Drugs 2022,20(1),53","journal-title":"Mar Drugs"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e00734","DOI":"10.1016\/j.sciaf.2021.e00734","volume":"12","author":"Olasupo S.B.","year":"2021","unstructured":"Olasupo S.B.; Uzairu A.; Shallangwa G.A.; Uba S.; Computer-aided drug design and in silico pharmacokinetics predictions of some potential antipsychotic agents. Sci Am 2021,12,e00734","journal-title":"Sci Am"},{"key":"ref=34","unstructured":"Expert Committee on Drug Dependence WHO Expert Committee on Drug Dependence: fortieth report World Health Organization (WHO)Available from:  [Accessed on: May 28, 2022].","journal-title":"Expert Committee on Drug Dependence WHO Expert Committee on Drug Dependence: fortieth report"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"Thijs R.D.","year":"2019","unstructured":"Thijs R.D.; Surges R.; O\u2019Brien T.J.; Sander J.W.; Epilepsy in adults. Lancet 2019,393(10172),689-701","journal-title":"Lancet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1055\/s-0040-1718719","volume":"40","author":"Falco-Walter J.","year":"2020","unstructured":"Falco-Walter J.; Epilepsy-definition, classification, pathophysiology, and epidemiology. Semin Neurol 2020,40(6),617-623","journal-title":"Semin Neurol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.5694\/mja17.00951","volume":"208","author":"Perucca P.","year":"2018","unstructured":"Perucca P.; Scheffer I.E.; Kiley M.; The management of epilepsy in children and adults. Med J Aust 2018,208(5),226-233","journal-title":"Med J Aust"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"730257","DOI":"10.3389\/fphar.2021.730257","volume":"12","author":"L&#xF6;scher W.","year":"2021","unstructured":"L&#xF6;scher W.; Single-Target versus multi-target drugs versus combinations of drugs with multiple targets: Preclinical and clinical evidence for the treatment or prevention of epilepsy. Front Pharmacol 2021,12,730257","journal-title":"Front Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"105974","DOI":"10.1016\/j.ejps.2021.105974","volume":"166","author":"Valipour M.","year":"2021","unstructured":"Valipour M.; Naderi N.; Heidarli E.; Shaki F.; Motafeghi F.; Talebpour Amiri F.; Emami S.; Irannejad H.; Design, synthesis and biological evaluation of naphthalene-derived (arylalkyl)azoles containing heterocyclic linkers as new anticonvulsants: A comprehensive in silico, in vitro, and in vivo study. Eur J Pharm Sci 2021,166,105974","journal-title":"Eur J Pharm Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1109\/TCBB.2018.2855138","volume":"16","author":"Rampogu S.","year":"2019","unstructured":"Rampogu S.; Park S.J.; Lee K.W.; Baek A.; Bavi R.; Son M.; Cao G.P.; Kumar R.; Park C.; Zeb A.; Rana R.M.; Identification of novel scaffolds with dual role as antiepileptic and anti-breast cancer. IEEE\/ACM Trans. Comput Biol Bioinform 2019,16(5),1663-1674","journal-title":"Comput Biol Bioinform"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"103004","DOI":"10.1016\/j.bioorg.2019.103004","volume":"89","year":"2019","unstructured":"T&#xFC;rke&#x15F; C.; Arslan, M.; Demir, Y.; &#xC7;o&#xE7;aj, L.; Rifati Nixha, A.; Beydemir, &#x15E;. Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorg Chem 2019,89,103004","journal-title":"Bioorg Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.molstruc.2019.07.070","volume":"1197","author":"Nadaroglu H.","year":"2019","unstructured":"Nadaroglu H.; Gungor A.A.; Gundogdu &#xD6;.; Kishali N.H.; Sever B.; Altintop M.D.; Investigation of the inhibitory effects of isoindoline-1,3-dion derivatives on hCA-I and hCA-II enzyme activities. J Mol Struct 2019,1197,386-392","journal-title":"J Mol Struct"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"103096","DOI":"10.1016\/j.bioorg.2019.103096","volume":"90","author":"Bayindir S.","year":"2019","unstructured":"Bayindir S.; Caglayan C.; Karaman M.; G&#xFC;lcin, \u0130. The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes. Bioorg Chem 2019,90,103096","journal-title":"Bioorg Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"104943","DOI":"10.1016\/j.bioorg.2021.104943","volume":"112","author":"Emami S.","year":"2021","unstructured":"Emami S.; Valipour M.; Kazemi Komishani F.; Sadati-Ashrafi F.; Rasoulian M.; Ghasemian M.; Tajbakhsh M.; Honarchian Masihi P.; Shakiba A.; Irannejad H.; Ahangar N.; Synthesis, in silico, in vitro and in vivo evaluations of isatin aroylhydrazones as highly potent anticonvulsant agents. Bioorg Chem 2021,112(112),104943","journal-title":"Bioorg Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-804766-8.00009-1","volume":"167","author":"Lopez O.L.","year":"2019","unstructured":"Lopez O.L.; Kuller L.H.; Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer\u2019s disease and other dementias. Handb Clin Neurol 2019,167,139-148","journal-title":"Handb Clin Neurol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"Frisoni G.B.","year":"2022","unstructured":"Frisoni G.B.; Altomare D.; Thal D.R.; Ribaldi F.; van der Kant R.; Ossenkoppele R.; Blennow K.; Cummings J.; van Duijn C.; Nilsson P.M.; Dietrich P.Y.; Scheltens P.; Dubois B.; The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci 2022,23(1),53-66","journal-title":"Nat Rev Neurosci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"Kumar V.","year":"2022","unstructured":"Kumar V.; Kundu S.; Singh A.; Singh S.; Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective. Curr Neuropharmacol 2022,20(1),158-178","journal-title":"Curr Neuropharmacol"},{"key":"ref=48","author":"Sobko A.","year":"2021","unstructured":"Sobko A.;  Cell Biologist\u2019s Perspective: Frontiers in Development of PROTAC-Mediated HDAC Degraders; OSF Prepr INCOMPLETE2021","journal-title":"Cell Biologist\u2019s Perspective: Frontiers in Development of PROTAC-Mediated HDAC Degraders; OSF Prepr"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/med.21701","volume":"40","author":"Rodrigues D.A.","year":"2020","unstructured":"Rodrigues D.A.; Pinheiro P.S.M.; Sagrillo F.S.; Bolognesi M.L.; Fraga C.A.M.; Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities. Med Res Rev 2020,40(6),2177-2211","journal-title":"Med Res Rev"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"112193","DOI":"10.1016\/j.ejmech.2020.112193","volume":"192","author":"Tseng H.J.","year":"2020","unstructured":"Tseng H.J.; Lin M.H.; Shiao Y.J.; Yang Y.C.; Chu J.C.; Chen C.Y.; Chen Y.Y.; Lin T.E.; Su C.J.; Pan S.L.; Chen L.C.; Wang C.Y.; Hsu K.C.; Huang W.J.; Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer\u2019s disease. Eur J Med Chem 2020,192,112193","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/cmdc.202000643","volume":"16","author":"Rodrigues D.A.","year":"2021","unstructured":"Rodrigues D.A.; Pinheiro P.S.M.; Fraga C.A.M.; Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol\u20103\u2010kinase (PI3K): Current and future prospects. ChemMedChem 2021,16(3),448-457","journal-title":"ChemMedChem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/cmdc.201900174","volume":"14","author":"De Simone A.","year":"2019","unstructured":"De Simone A.; Milelli A.; Histone deacetylase inhibitors as multitarget ligands: New players in Alzheimer\u2019s disease drug discovery? ChemMedChem 2019,14(11),1067-1073","journal-title":"ChemMedChem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","volume":"16","author":"Briggs R.","year":"2016","unstructured":"Briggs R.; Kennelly S.P.; O\u2019Neill D.; Drug treatments in Alzheimer\u2019s disease. Clin Med (Lond) 2016,16(3),247-253","journal-title":"Clin Med (Lond)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/JAD-180766","volume":"67","author":"Cummings J.L.","year":"2019","unstructured":"Cummings J.L.; Tong G.; Ballard C.; Treatment Combinations for Alzheimer\u2019s Disease: Current and future pharmacotherapy options. J Alzheimers Dis 2019,67(3),779-794","journal-title":"J Alzheimers Dis"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","volume":"41","author":"Benek O.","year":"2020","unstructured":"Benek O.; Korabecny J.; Soukup O.; A perspective on multi-target drugs for Alzheimer\u2019s Disease. Trends Pharmacol Sci 2020,41(7),434-445","journal-title":"Trends Pharmacol Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/acsmedchemlett.9b00071","volume":"10","author":"Soares Romeiro L.A.","year":"2019","unstructured":"Soares Romeiro L.A.; da Costa Nunes J.L.; de Oliveira Miranda C.; Sim&#xF5;es Heyn Roth Cardoso G.; de Oliveira A.S.; Gandini A.; Kobrlova T.; Soukup O.; Rossi M.; Senger J.; Jung M.; Gervasoni S.; Vistoli G.; Petralla S.; Massenzio F.; Monti B.; Bolognesi M.L.; Novel sustainable-by-Design HDAC inhibitors for the treatment of Alzheimer\u2019s Disease. ACS Med Chem Lett 2019,10(4),671-676","journal-title":"ACS Med Chem Lett"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12017-021-08660-4","volume":"23","author":"Athira K.V.","year":"2021","unstructured":"Athira K.V.; Sadanandan P.; Chakravarty S.; Repurposing vorinostat for the treatment of disorders affecting brain. NeuroMol. Med 2021,23(4),449-465","journal-title":"Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/npp.2009.197","volume":"35","author":"Kilgore M.","year":"2010","unstructured":"Kilgore M.; Miller C.A.; Fass D.M.; Hennig K.M.; Haggarty S.J.; Sweatt J.D.; Rumbaugh G.; Inhibitors of Class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s Disease. Neuropsychopharmacol 2010,35(4),870-880","journal-title":"Neuropsychopharmacol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3390\/pharmaceutics13111893","volume":"13","author":"Neganova M.","year":"2021","unstructured":"Neganova M.; Aleksandrova Y.; Suslov E.; Mozhaitsev E.; Munkuev A.; Tsypyshev D.; Chicheva M.; Rogachev A.; Sukocheva O.; Volcho K.; Klochkov S.; Novel multitarget hydroxamic acids with a natural origin CAP group against Alzheimer\u2019s Disease: Synthesis, docking and biological evaluation. Pharmaceutics 2021,13(11),1893","journal-title":"Pharmaceutics"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"17602","DOI":"10.1039\/D0RA00663G","volume":"10","author":"Mishra C.B.","year":"2020","unstructured":"Mishra C.B.; Shalini S.; Gusain S.; Prakash A.; Kumari J.; Kumari S.; Yadav A.K.; Lynn A.M.; Tiwari M.; Development of novel N -(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-&#x3B2;-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer\u2019s disease. RSC Advances 2020,10(30),17602-17619","journal-title":"RSC Advances"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2000282","DOI":"10.1002\/ardp.202000282","volume":"354","year":"2021","unstructured":"Kalayc\u0131 M.; T&#xFC;rke&#x15F; C.; Arslan, M.; Demir, Y.; Beydemir, &#x15E;. Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors. Arch Pharm (Weinheim) 2021,354(3),2000282","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acschemneuro.0c00706","volume":"12","author":"Titov A.A.","year":"2021","unstructured":"Titov A.A.; Kobzev M.S.; Catto M.; Candia M.; Gambacorta N.; Denora N.; Pisani L.; Nicolotti O.; Borisova T.N.; Varlamov A.V.; Voskressensky L.G.; Altomare C.D.; Away from Flatness: Unprecedented Nitrogen-Bridged Cyclopenta[ a]indene Derivatives as Novel Anti-Alzheimer Multitarget Agents. ACS Chem Neurosci 2021,12(2),340-353","journal-title":"ACS Chem Neurosci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1021\/acschemneuro.0c00448","volume":"11","author":"Patel D.V.","year":"2020","unstructured":"Patel D.V.; Patel N.R.; Kanhed A.M.; Teli D.M.; Patel K.B.; Gandhi P.M.; Patel S.P.; Chaudhary B.N.; Shah D.B.; Prajapati N.K.; Patel K.V.; Yadav M.R.; Further studies on triazinoindoles as potential novel multitarget-directed anti-Alzheimer\u2019s agents. ACS Chem Neurosci 2020,11(21),3557-3574","journal-title":"ACS Chem Neurosci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3390\/ph14090937","volume":"14","author":"Iqbal D.","year":"2021","unstructured":"Iqbal D.; Rehman M.T.; Bin Dukhyil A.; Rizvi S.M.D.; Al Ajmi M.F.; Alshehri B.M.; Banawas S.; Khan M.S.; Alturaiki W.; Alsaweed M.; High-throughput screening and molecular dynamics simulation of natural product-like compounds against Alzheimer\u2019s Disease through multitarget approach. Pharmaceuticals (Basel) 2021,14(9),937","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"173875","DOI":"10.1016\/j.ejphar.2021.173875","volume":"895","author":"S&#xE1;nchez Montero J.M.","year":"2021","unstructured":"S&#xE1;nchez Montero J.M.; Agis-Torres A.; Solano D.; S&#xF6;llhuber M.; Fernandez M.; Villaro W.; G&#xF3;mez-Ca&#xF1;as M.; Garc&#xED;a-Arencibia M.; Fern&#xE1;ndez-Ruiz J.; Egea J.; Mart&#xED;n M.I.; Gir&#xF3;n R.; Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer\u2019s disease. Eur J Pharmacol 2021,895,173875","journal-title":"Eur J Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"103977","DOI":"10.1016\/j.bioorg.2020.103977","volume":"101","author":"Patel D.V.","year":"2020","unstructured":"Patel D.V.; Patel N.R.; Kanhed A.M.; Teli D.M.; Patel K.B.; Joshi P.D.; Patel S.P.; Gandhi P.M.; Chaudhary B.N.; Prajapati N.K.; Patel K.V.; Yadav M.R.; Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents. Bioorg Chem 2020,101,103977","journal-title":"Bioorg Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"115721","DOI":"10.1016\/j.bmc.2020.115721","volume":"28","author":"Choubey P.K.","year":"2020","unstructured":"Choubey P.K.; Tripathi A.; Sharma P.; Shrivastava S.K.; Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 2020,28(22),115721","journal-title":"Bioorg Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"116660","DOI":"10.1016\/j.bmc.2022.116660","volume":"58","author":"Liu Z.","year":"2022","unstructured":"Liu Z.; Shi Y.; Zhang X.; Yu G.; Li J.; Cong S.; Deng Y.; Discovery of novel 3-butyl-6-benzyloxyphthalide Mannich base derivatives as multifunctional agents against Alzheimer\u2019s disease. Bioorg Med Chem 2022,58,116660","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1016\/j.csbj.2021.07.041","volume":"19","author":"Remya C.","year":"2021","unstructured":"Remya C.; Dileep K.V.; Koti Reddy E.; Mantosh K.; Lakshmi K.; Sarah Jacob R.; Sajith A.M.; Jayadevi Variyar E.; Anwar S.; Zhang K.Y.J.; Sadasivan C.; Omkumar R.V.; Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase \u2013 Design, synthesis and biological evaluation. Comput Struct Biotechnol J 2021,19,4517-4537","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1016\/j.csbj.2021.11.035","volume":"19","author":"Namasivayam V.","year":"2021","unstructured":"Namasivayam V.; Stefan K.; Pahnke J.; Stefan S.M.; Binding mode analysis of ABCA7 for the prediction of novel Alzheimer\u2019s disease therapeutics. Comput Struct Biotechnol J 2021,19,6490-6504","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1021\/acssensors.1c00338","volume":"6","author":"Elbatrawy A.A.","year":"2021","unstructured":"Elbatrawy A.A.; Hyeon S.J.; Yue N.; Osman E.E.A.; Choi S.H.; Lim S.; Kim Y.K.; Ryu H.; Cui M.; Nam G.; &#x201C;Turn-On&#x201D; Quinoline-Based fluorescent probe for selective imaging of tau aggregates in Alzheimer\u2019s Disease: Rational design, synthesis, and molecular docking. ACS Sens 2021,6(6),2281-2289","journal-title":"ACS Sens"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbi.2015.07.008","volume":"240","author":"Hung T.M.","year":"2015","unstructured":"Hung T.M.; Lee J.S.; Chuong N.N.; Kim J.A.; Oh S.H.; Woo M.H.; Choi J.S.; Min B.S.; Kinetics and molecular docking studies of cholinesterase inhibitors derived from water layer of Lycopodiella cernua (L.) Pic. Serm. (II). Chem Biol Interact 2015,240,74-82","journal-title":"Chem Biol Interact"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3390\/ijms20112818","volume":"20","author":"van den Bos M.A.J.","year":"2019","unstructured":"van den Bos M.A.J.; Geevasinga N.; Higashihara M.; Menon P.; Vucic S.; Pathophysiology and diagnosis of ALS: Insights from advances in neurophysiological techniques. Int J Mol Sci 2019,20(11),2818","journal-title":"Int J Mol Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/WCO.0000000000000864","volume":"33","author":"Norris S.P.","year":"2020","unstructured":"Norris S.P.; Likanje M.F.N.; Andrews J.A.; Amyotrophic lateral sclerosis: Update on clinical management. Curr Opin Neurol 2020,33(5),641-648","journal-title":"Curr Opin Neurol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"107986","DOI":"10.1016\/j.neuropharm.2020.107986","volume":"167","author":"Chi&#xF2; A.","year":"2020","unstructured":"Chi&#xF2; A.; Mazzini L.; Mora G.; Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology 2020,167,107986","journal-title":"Neuropharmacology"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijbiomac.2020.01.032","volume":"147","author":"Girdhar A.","year":"2020","unstructured":"Girdhar A.; Bharathi V.; Tiwari V.R.; Abhishek S.; Deeksha W.; Mahawar U.S.; Raju G.; Singh S.K.; Prabusankar G.; Rajakumara E.; Patel B.K.; Computational insights into mechanism of AIM4-mediated inhibition of aggregation of TDP-43 protein implicated in ALS and evidence for in vitro inhibition of liquid-liquid phase separation (LLPS) of TDP-432C-A315T by AIM4. Int J Biol Macromol 2020,147,117-130","journal-title":"Int J Biol Macromol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1021\/acs.jmedchem.1c01255","volume":"65","author":"Mart&#xED;n-C&#xE1;mara O.","year":"2022","unstructured":"Mart&#xED;n-C&#xE1;mara O.; Arribas M.; Wells G.; Morales-Tenorio M.; Mart&#xED;n-Requero &#xC1;.; Porras G.; Mart&#xED;nez A.; Giorgi G.; L&#xF3;pez-Alvarado P.; Lastres-Becker I.; Men&#xE9;ndez J.C.; Multitarget Hybrid fasudil derivatives as a new approach to the potential treatment of amyotrophic lateral sclerosis. J Med Chem 2022,65(3),1867-1882","journal-title":"J Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"918811","DOI":"10.3389\/fnins.2022.918811","volume":"16","author":"Slota J.A.","year":"2022","unstructured":"Slota J.A.; Medina S.J.; Frost K.L.; Booth S.A.; Neurons and astrocytes elicit brain region specific transcriptional responses to prion disease in the murine CA1 and thalamus. Front Neurosci 2022,16,918811","journal-title":"Front Neurosci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3390\/ijms22042196","volume":"22","author":"Li B.","year":"2021","unstructured":"Li B.; Chen M.; Zhu C.; Neuroinflammation in prion disease. Int J Mol Sci 2021,22(4),2196","journal-title":"Int J Mol Sci"},{"key":"ref=80","author":"Kandel E.R.","year":"2018","unstructured":"Kandel E.R.;  The Disordered Mind: What Unusual Brains Tell Us about Ourselves 2018","journal-title":"The Disordered Mind: What Unusual Brains Tell Us about Ourselves"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"794646","DOI":"10.3389\/fmolb.2021.794646","volume":"8","author":"Salem A.","year":"2022","unstructured":"Salem A.; Wilson C.J.; Rutledge B.S.; Dilliott A.; Farhan S.; Choy W.Y.; Duennwald M.L.; Matrin3: Disorder and ALS pathogenesis. Front Mol Biosci 2022,8,794646","journal-title":"Front Mol Biosci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"105749","DOI":"10.1016\/j.nbd.2022.105749","volume":"170","author":"Hu L.","year":"2022","unstructured":"Hu L.; Mao S.; Lin L.; Bai G.; Liu B.; Mao J.; Stress granules in the spinal muscular atrophy and amyotrophic lateral sclerosis: The correlation and promising therapy. Neurobiol Dis 2022,170,105749","journal-title":"Neurobiol Dis"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1568026621666211015092047","volume":"22","author":"Rodrigues D.A.","year":"2022","unstructured":"Rodrigues D.A.; Roe A.; Griffith D.; Chonghaile T.N.; Advances in the design and development of PROTAC-mediated HDAC degradation. Curr Top Med Chem 2022,22(5),408-424","journal-title":"Curr Top Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"113749","DOI":"10.1016\/j.ejmech.2021.113749","volume":"225","author":"Wang C.","year":"2021","unstructured":"Wang C.; Zhang Y.; Wu Y.; Xing D.; Developments of CRBN-based PROTACs as potential therapeutic agents. Eur J Med Chem 2021,225,113749","journal-title":"Eur J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3881\/J.ISSN.1000-503X.2016.02.017","volume":"38","author":"Kong X.Y.","year":"2016","unstructured":"Kong X.Y.; Guan J.; Wang R.Z.; Molecular biological roles of oxidative stress in acute brain ischemia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2016,38(2),222-227","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mvr.2018.12.005","volume":"123","author":"Yang J.","year":"2019","unstructured":"Yang J.; The role of reactive oxygen species in angiogenesis and preventing tissue injury after brain ischemia. Microvasc Res 2019,123,62-67","journal-title":"Microvasc Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14656566.2020.1856815","volume":"22","author":"Kannan A.","year":"2021","unstructured":"Kannan A.; Delgardo M.; Pennington-FitzGerald W.; Jiang E.X.; Christophe B.R.; Connolly E.S.; Pharmacological management of cerebral ischemia in the elderly. Expert Opin Pharmacother 2021,22(7),897-906","journal-title":"Expert Opin Pharmacother"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.2147\/IJGM.S345884","volume":"15","author":"Xiong L.","year":"2022","unstructured":"Xiong L.; Liu S.C.; Huo S.Y.; Pu L.Q.; Li J.J.; Bai W.Y.; Yang Y.; Shao J.L.; Exploration in the therapeutic and multi-target mechanism of ketamine on cerebral ischemia based on network pharmacology and molecular docking. Int J Gen Med 2022,15,4195-4208","journal-title":"Int J Gen Med"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.pharep.2018.02.013","volume":"70","author":"Nu&#xF1;ez-Figueredo Y.","year":"2018","unstructured":"Nu&#xF1;ez-Figueredo Y.; Ram&#xED;rez-S&#xE1;nchez J.; Pardo Andreu G.L.; Ochoa-Rodr&#xED;guez E.; Verdecia-Reyes Y.; Souza D.O.; Multi-targeting effects of a new synthetic molecule (JM-20) in experimental models of cerebral ischemia. Pharmacol Rep 2018,70(4),699-704","journal-title":"Pharmacol Rep"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"113061","DOI":"10.1016\/j.ejmech.2020.113061","volume":"210","author":"Rocchi D.","year":"2021","unstructured":"Rocchi D.; Bl&#xE1;zquez-Barbadillo C.; Agamennone M.; Laghezza A.; Tortorella P.; Vicente-Zurdo D.; Rosales-Conrado N.; Moyano P.; Pino J.; Gonz&#xE1;lez J.F.; Men&#xE9;ndez J.C.; Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity. Eur J Med Chem 2021,210,113061","journal-title":"Eur J Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jphs.2019.12.008","volume":"142","author":"Hu H.","year":"2020","unstructured":"Hu H.; Zhou S.; Sun X.; Xue Y.; Yan L.; Sun X.; Lei M.; Li J.; Zeng X.; Hao L.; A potent antiarrhythmic drug N-methyl berbamine extends the action potential through inhibiting both calcium and potassium currents. J Pharmacol Sci 2020,142(4),131-139","journal-title":"J Pharmacol Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00210-019-01670-x","volume":"392","author":"Kumar G.","year":"2019","unstructured":"Kumar G.; Mukherjee S.; Paliwal P.; Singh S.; Sen; Birla, H.; Singh, S. P.; Krishnamurthy, S.; Patnaik, R. Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model. Naunyn Schmiedeberg\u2019s Arch Pharmacol 2019,392(10),1293-1309","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1875-5364(21)60079-1","volume":"19","author":"Gao Q.","year":"2021","unstructured":"Gao Q.; Han Z.Y.; Tian D.F.; Liu G.L.; Wang Z.Y.; Lin J.F.; Chang Z.; Zhang D.D.; Xie Y.Z.; Sun Y.K.; Yao X.W.; Ma D.Y.; Xinglou Chengqi Decoction improves neurological function in experimental stroke mice as evidenced by gut microbiota analysis and network pharmacology. Chin J Nat Med 2021,19(12),881-899","journal-title":"Chin J Nat Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/1039856218791036","volume":"26","author":"Goh A.M.Y.","year":"2018","unstructured":"Goh A.M.Y.; Wibawa P.; Loi S.M.; Walterfang M.; Velakoulis D.; Looi J.C.L.; Huntington\u2019s disease: Neuropsychiatric manifestations of Huntington\u2019s disease. Australas Psychiatry 2018,26(4),366-375","journal-title":"Australas Psychiatry"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"Tabrizi S.J.","year":"2020","unstructured":"Tabrizi S.J.; Flower M.D.; Ross C.A.; Wild E.J.; Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 2020,16(10),529-546","journal-title":"Nat Rev Neurol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","volume":"16","author":"Wild E.J.","year":"2017","unstructured":"Wild E.J.; Tabrizi S.J.; Therapies targeting DNA and RNA in Huntington\u2019s disease. Lancet Neurol 2017,16(10),837-847","journal-title":"Lancet Neurol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/14728222.2018.1465930","volume":"22","author":"Saavedra A.","year":"2018","unstructured":"Saavedra A.; Garc&#xED;a-D&#xED;az Barriga G.; P&#xE9;rez-Navarro E.; Alberch J.; Huntington\u2019s disease: Novel therapeutic perspectives hanging in the balance. Expert Opin Ther Targets 2018,22(5),385-399","journal-title":"Expert Opin Ther Targets"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"6020197","DOI":"10.1155\/2018\/6020197","volume":"2018","author":"Dai W.","year":"2018","unstructured":"Dai W.; Chen H.Y.; Chen C.Y.C.; A network pharmacology-based approach to investigate the novel TCM Formula against Huntington\u2019s Disease and validated by support vector machine model. Evid Based Complement Alternat Med 2018,2018,6020197","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","volume":"226","author":"Raza C.","year":"2019","unstructured":"Raza C.; Anjum R.; Shakeel N.A.; Parkinson\u2019s disease: Mechanisms, translational models and management strategies. Life Sci 2019,226,77-90","journal-title":"Life Sci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"Cerri S.","year":"2019","unstructured":"Cerri S.; Mus L.; Blandini F.; Parkinson\u2019s disease in women and men: What\u2019s the difference? J Parkinsons Dis 2019,9(3),501-515","journal-title":"J Parkinsons Dis"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"Mahoney-S&#xE1;nchez L.","year":"2021","unstructured":"Mahoney-S&#xE1;nchez L.; Bouchaoui H.; Ayton S.; Devos D.; Duce J.A.; Devedjian J.C.; Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s Disease. Prog Neurobiol 2021,196,101890","journal-title":"Prog Neurobiol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3389\/fnins.2019.01443","volume":"13","author":"Yan N.","year":"2020","unstructured":"Yan N.; Zhang J.; Iron metabolism, ferroptosis, and the links with Alzheimer\u2019s disease. Front Neurosci 2020,13,1443","journal-title":"Front Neurosci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2174\/1389557519666191104110908","volume":"20","author":"Marino B.L.B.","year":"2020","unstructured":"Marino B.L.B.; de Souza L.R.; Sousa K.P.A.; Ferreira J.V.; Padilha E.C.; da Silva C.H.T.P.; Taft C.A.; Hage-Melim L.I.S.; Parkinson\u2019s disease: A review from pathophysiology to treatment. Mini Rev Med Chem 2020,20(9),754-767","journal-title":"Mini Rev Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s11064-019-02798-1","volume":"44","author":"T&#xF3;th A.","year":"2019","unstructured":"T&#xF3;th A.; Antal Z.; Bereczki D.; Sperl&#xE1;gh B.; Purinergic Signalling in Parkinson\u2019s Disease: A multi-target system to combat neurodegeneration. Neurochem Res 2019,44(10),2413-2422","journal-title":"Neurochem Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.4155\/fmc-2021-0217","volume":"13","author":"Sasaki N.A.","year":"2021","unstructured":"Sasaki N.A.; Sonnet P.; A novel multi-target strategy to attenuate the progression of Parkinson\u2019s disease by diamine hybrid AGE\/ALE inhibitor. Future Med Chem 2021,13(24),2185-2200","journal-title":"Future Med Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12539-020-00359-7","volume":"12","author":"Li L.","year":"2020","unstructured":"Li L.; Qiu H.; Liu M.; Cai Y.; A network pharmacology-based study of the molecular mechanisms of Shaoyao-Gancao Decoction in treating Parkinson\u2019s Disease. Interdiscip Sci 2020,12(2),131-144","journal-title":"Interdiscip Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"115640","DOI":"10.1016\/j.bmc.2020.115640","volume":"28","author":"Maqbool M.","year":"2020","unstructured":"Maqbool M.; Rajvansh R.; Srividya K.; Hoda N.; Deciphering the robustness of pyrazolo-pyridine carboxylate core structure-based compounds for inhibiting &#x3B1;-synuclein in transgenic C. elegans model of Synucleinopathy. Bioorg Med Chem 2020,28(17),115640","journal-title":"Bioorg Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.4103\/1673-5374.309843","volume":"16","author":"Anastassova N.","year":"2021","unstructured":"Anastassova N.; Aluani D.; Kostadinov A.; Rangelov M.; Todorova N.; Hristova-Avakumova N.; Argirova M.; Lumov N.; Kondeva-Burdina M.; Tzankova V.; Yancheva D.; Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation. Neural Regen Res 2021,16(11),2299-2309","journal-title":"Neural Regen Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/antiox10101641","volume":"10","author":"Elsherbeny M.H.","year":"2021","unstructured":"Elsherbeny M.H.; Kim J.; Gouda N.A.; Gotina L.; Cho J.; Pae A.N.; Lee K.; Park K.D.; Elkamhawy A.; Roh E.J.; Highly potent, selective, and competitive indole-based MAO-B inhibitors protect PC12 cells against 6-Hydroxydopamine- and Rotenone-induced oxidative stress. Antioxidants 2021,10(10),1641","journal-title":"Antioxidants"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/antiox10101604","volume":"10","author":"Elkamhawy A.","year":"2021","unstructured":"Elkamhawy A.; Woo J.; Gouda N.A.; Kim J.; Nada H.; Roh E.J.; Park K.D.; Cho J.; Lee K.; Melatonin analogues potently inhibit MAO-B and protect PC12 cells against oxidative stress. Antioxidants 2021,10(10),1604","journal-title":"Antioxidants"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.bmc.2019.02.004","volume":"27","year":"2019","unstructured":"Za\u0142uski, M.; Schabikowski, J.; Schlenk, M.; Olejarz-Maciej, A.; Kubas, B.; Karcz, T.; Kuder, K.; Latacz, G.; Zygmunt, M.; Synak, D.; Hinz, S.; M&#xFC;ller, C.E.; Kie\u0107-Kononowicz, K. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies. Bioorg Med Chem 2019,27(7),1195-1210","journal-title":"Bioorg Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/md17060377","volume":"17","author":"Seong S.H.","year":"2019","unstructured":"Seong S.H.; Paudel P.; Choi J.W.; Ahn D.H.; Nam T.J.; Jung H.A.; Choi J.S.; Probing multi-target action of phlorotannins as new monoamine oxidase inhibitors and dopaminergic receptor modulators with the potential for treatment of neuronal disorders. Mar Drugs 2019,17(6),377","journal-title":"Mar Drugs"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"104764","DOI":"10.1016\/j.jff.2021.104764","volume":"87","author":"Li F.","year":"2021","unstructured":"Li F.; Hatano T.; Hattori N.; Systematic analysis of the molecular mechanisms mediated by coffee in Parkinson\u2019s disease based on network pharmacology approach. J Funct Foods 2021,87,104764","journal-title":"J Funct Foods"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666230126112628","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213176\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666230126112628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:13:37Z","timestamp":1683112417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213176\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026623666230126112628","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}